Novel endocannabinoids and cannabilactones
N-arachidonoylethanolamine (AEA) and 2-arachidonoyl glycerol (2-AG) are the two well recognized endocannabinoids (eCBs) for the CB receptors, which are currently being targeted for a number of conditions including pain, inflammation, CNS disorders and cancer. However, the metabolic instability of th...
| Published: |
|
|---|---|
| Online Access: | http://hdl.handle.net/2047/D20356167 |